Direct Biologics

Direct Biologics company information, Employees & Contact Information

Explore related pages

Related company profiles:

Direct Biologics is a market-leading innovator in regenerative medicine.

Company Details

Employees
55
Address
1529 Barton Springs Rd,
Phone
800-791-1021
Email
in****@****ics.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
Athens.
HQ
Austin, Texas
Looking for a particular Direct Biologics employee's phone or email?

Direct Biologics Questions

News

Direct Biologics’ Phase 1 Clinical Trial Seeks to Treat Crohn Disease With Extracellular Vesicles - CGTLive®

Direct Biologics’ Phase 1 Clinical Trial Seeks to Treat Crohn Disease With Extracellular Vesicles CGTLive®

Direct Biologics, LLC Announces One Year Follow Up of Pilot Safety Study of ExoFlo for Treatment of Osteoarthritis in Combat-Related Injuries - Yahoo Finance

Direct Biologics, LLC Announces One Year Follow Up of Pilot Safety Study of ExoFlo for Treatment of Osteoarthritis in Combat-Related Injuries Yahoo Finance

Direct Biologics Receives FDA Approval to Initiate ‘EXIT COVID-19,’ a Phase II Investigational New Drug Trial with ExoFlo - BioInformant

Direct Biologics Receives FDA Approval to Initiate ‘EXIT COVID-19,’ a Phase II Investigational New Drug Trial with ExoFlo BioInformant

Direct Biologics Appoints Dr. Amy Lightner as Chief Medical Officer - citybiz

Direct Biologics Appoints Dr. Amy Lightner as Chief Medical Officer citybiz

Direct Biologics Announces New Advanced Tool in Regenerative Medicine with Launch of AmnioWrap™ Placental Allograft - Newswire.com

Direct Biologics Announces New Advanced Tool in Regenerative Medicine with Launch of AmnioWrap™ Placental Allograft Newswire.com

FDA grants RMAT designation to Direct Biologics’ EV drug for Covid-19 - Pharmaceutical Technology

FDA grants RMAT designation to Direct Biologics’ EV drug for Covid-19 Pharmaceutical Technology

Direct Biologics - The Pharma Letter

Direct Biologics The Pharma Letter

Direct Biologics Receives FDA Approval to Proceed with Second ExoFlo IND for Post-Acute COVID-19 Syndrome and Chronic Post-COVID-19 Syndrome - BioInformant

Direct Biologics Receives FDA Approval to Proceed with Second ExoFlo IND for Post-Acute COVID-19 Syndrome and Chronic Post-COVID-19 Syndrome BioInformant

Good Works II Acquisition Terminates $675M Direct Biologics Deal - The SPAC Conference

Good Works II Acquisition Terminates $675M Direct Biologics Deal The SPAC Conference

Direct Biologics Granted FDA Approval of Third IND Application for the Use of ExoFlo in Mild-to-Moderate COVID-19 Infusion Therapy - Newswire.com

Direct Biologics Granted FDA Approval of Third IND Application for the Use of ExoFlo in Mild-to-Moderate COVID-19 Infusion Therapy Newswire.com

Tr1 Treg Therapy to be Evaluated in Trial for Crohn Disease - CGTLive®

Tr1 Treg Therapy to be Evaluated in Trial for Crohn Disease CGTLive®

FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial - BioInformant

FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial BioInformant

APEX Biologix, LLC Announces Agreement With New Exosome Supplier - Newswire.com

APEX Biologix, LLC Announces Agreement With New Exosome Supplier Newswire.com

Direct Biologics Announces Significant Survival Benefit with ExoFlo™ in its Phase 2 Randomized Clinical Trial - BioInformant

Direct Biologics Announces Significant Survival Benefit with ExoFlo™ in its Phase 2 Randomized Clinical Trial BioInformant

Top Direct Biologics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant